A Signaling View into the Inflammatory Tumor Microenvironment

نویسندگان

چکیده

The development of tumors requires an initiator event, usually exposure to DNA damaging agents that cause genetic alterations such as gene mutations or chromosomal abnormalities, leading deregulated cell proliferation. Although the mere stochastic accumulation further may tumor progression, it is now clear inflammatory microenvironment has a major tumor-promoting influence on initiated cells, in particular when chronic reaction already existed before was formed. Moreover, cells become mobilized response signals emanating from cells. In both cases, provides perceive by membrane receptors and transduce via downstream kinase cascades modulate multiple cellular processes respond with changes expression, metabolism, morphology. Cytokines, chemokines, growth factors are examples secreted immune fibroblast, endothelial mediate intricate cell-cell crosstalk microenvironment, which contributes increased cancer survival, phenotypic plasticity adaptation surrounding tissue conditions. Eventually, consequent extracellular matrix stiffness architecture, coupled additional alterations, fortify malignant progression priming them for invasion metastasis. Here, we provide overview current knowledge composition emphasis signal-transducing events mediating different aspects stromal cell-tumor communication ultimately lead progression.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

A top-down view of the tumor microenvironment: structure, cells and signaling

It is well established that the tumor microenvironment (TME) contributes to cancer progression. Stromal cells can be divided into mesenchymal, vascular, and immune. Signaling molecules secreted by the tumor corrupts these cells to create "activated" stroma. Equally, the extracellular matrix (ECM) contributes to tumor development and invasion by forming a biologically active scaffold. In this re...

متن کامل

The tumor microenvironment and inflammatory breast cancer

Inflammatory breast cancer (IBC) is a rare and very aggressive subtype of breast cancer with clinical manifestations similar to acute inflammation. The prognosis of IBC is still poor even though combination therapy with surgery, chemotherapy, and target therapy, mainly due to a lack of fully understanding of the cellular and molecular mechanisms of IBC pathogenesis and progression. In the prese...

متن کامل

Tumor Inflammatory Microenvironment in EMT and Metastasis

Approximately 90% of cancer-related death is caused by metastasis. The increased motility and invasiveness of metastatic tumor cells is reminiscent of events that occur at the epithelial-mesenchymal transition (EMT), which is a characteristic that occurs during embryonic development, tissue remodeling, wound healing and metastasis. Interestingly, EMT is a dynamic process and mainly occurs at th...

متن کامل

Turning the tumor microenvironment into a self vaccine site

We aimed to determine if the tumor microenvironment could be turned into a "self"-vaccine site. We show that provoking a local inflammatory response modulates endothelia to permit the infiltration of innate and adaptive effector cells which collaborate to eradicate the inflamed tumor and other tumor deposits, and provide long-term protection.

متن کامل

Inflammatory Alterations of the Extracellular Matrix in the Tumor Microenvironment

Complex interactions between cancer cells and host stromal cells result in the formation of the "tumor microenvironment", where inflammatory alterations involve the infiltration of tumor-associated fibroblasts and inflammatory leukocytes that contribute to the acquisition of malignant characteristics, such as increased cancer cell proliferation, invasiveness, metastasis, angiogenesis, and avoid...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Immuno

سال: 2021

ISSN: ['2673-5601']

DOI: https://doi.org/10.3390/immuno1020007